CLOV vs ORGO · rev $1.37B vs rev $482.0M
Clover Health Investments Corp (CLOV) versus Organogenesis Holdings Inc (ORGO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported ORGO revenue for 2024-12-31 was $482.0M. Net income was $861.0K. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. ORGO currently screens at market cap $301.1M.
CLOV currently screens at market cap $1.55B. ORGO currently screens at market cap $301.1M.
Not investment advice. Open the CLOV and ORGO stock pages for the full models.
Not investment advice.